Cas 854933-18-9,Propanoic acid, 2-[3-[[2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl]methyl]phenoxy]-, (2S)-

854933-18-9

Post Buying Request

Basic information

Product Name: Propanoic acid, 2-[3-[[2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl]methyl]phenoxy]-, (2S)-
Synonyms:
CAS NO:854933-18-9
Molecular Formula: C20H18F3NO4
Molecular Weight: 393.362
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Propanoic acid, 2-[3-[[2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl]methyl]phenoxy]-, (2S)-(CAS DataBase Reference)
NIST Chemistry Reference: Propanoic acid, 2-[3-[[2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl]methyl]phenoxy]-, (2S)-(854933-18-9)
EPA Substance Registry System: Propanoic acid, 2-[3-[[2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl]methyl]phenoxy]-, (2S)-(854933-18-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 854933-18-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

854933-18-9 Suppliers

Recommended suppliers

854933-18-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 854933-18-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,4,9,3 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 854933-18:
(8*8)+(7*5)+(6*4)+(5*9)+(4*3)+(3*3)+(2*1)+(1*8)=199
199 % 10 = 9
So 854933-18-9 is a valid CAS Registry Number.

854933-18-9Upstream product

393794-49-5 Allyl (2S)-2-(3-{[2-methyl-5-(trifluoromethoxy)-1H-indol-3-yl]methyl}phenoxy)propanoate

854933-18-9Downstream Products

854933-18-9Relevant academic research and scientific papers

PPAR-SPARING COMPOUNDS AND COMBINATIONS FORT THE TREATMENT OF DIABETES AND OTHER METABOLIC DISEASES

-

, (2013/02/28)

The present invention relates to compounds I and pharmaceutical compositions that are useful for treating and/or preventing diabetes or other metabolic diseases, optionally in combination with a second therapy such an active pharmaceutical agent or diet restriction or an increase in duration or exertion in physical activity.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 854933-18-9